KORNITZER CAPITAL MANAGEMENT INC /KS

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 898358 SHAWNEE MISSION, KS

Position in ARWR

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$2,243,406

-$132,028 QoQ

Shares Held

35,780

0.0% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

KORNITZER CAPITAL MANAGEMENT INC /KS holds $45,330,914 across 13 Biotechnology names. ARWR ranks #6 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	60,342	$12,047,280
2	HALO	Halozyme Therapeutics, Inc.	113,499	$7,335,440
3	TECH	BIO-TECHNE Corp	130,270	$6,807,910
4	ARQT	Arcutis Biotherapeutics, Inc.	175,870	$4,143,497
5	VCEL	Vericel Corp	113,944	$3,665,578
6	ARWR	Arrowhead Pharmaceuticals, Inc. This page	35,780	$2,243,406
7	ZYME	Zymeworks Inc.	88,800	$2,223,552
8	IONS	Ionis Pharmaceuticals Inc	29,105	$2,185,494

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,243,406	35,780	0.0%	Shares	Sole	2026-04-30
2025-12-31	$2,375,434	35,780	-71.7%	Shares	Sole	2026-02-02
2025-06-30	$1,998,858	126,510	0.0%	Shares	Sole	2025-07-31
2025-03-31	$1,611,737	126,510	0.0%	Shares	Sole	2025-05-02
2024-12-31	$2,378,388	126,510	0.0%	Shares	Sole	2025-01-31
2024-09-30	$2,450,498	126,510	0.0%	Shares	Sole	2024-10-31
2024-06-30	$3,287,994	126,510	0.0%	Shares	Sole	2024-08-02
2024-03-31	$3,618,186	126,510	0.0%	Shares	Sole	2024-05-02
2023-12-31	$3,871,206	126,510	0.0%	Shares	Sole	2024-01-31
2023-09-30	$3,399,323	126,510	0.0%	Shares	Sole	2023-10-31
2023-06-30	$4,511,346	126,510	0.0%	Shares	Sole	2023-08-01
2023-03-31	$3,213,354	126,510	+28.0%	Shares	Sole	2023-05-09
2022-12-31	$4,008,139	98,820	—	Shares	Sole	2023-02-02
No filing history on record for this holder in this stock.